je.st
news
Tag: salix
The Emperor Is 25% To 65% Naked: Valeant, Salix, And Cash EPS
2015-12-14 19:08:13| Biotech - Topix.net
Valeant's use of Cash EPS for depreciating durable assets seems inappropriate when applied to a finite portfolio of patent products like Salix. Using various depreciation schedules for the debt cost of acquiring Salix lowers VRX's cash EPS from 25% to 65%.
Valeant raises outlook after completing purchase of Salix
2015-04-30 09:04:09| Biotech - Topix.net
" Valeant Pharmaceuticals International Inc. said Wednesday it turned a profit in the first quarter, and the Canadian drugmaker raised its forecasts for the year after completing more acquisitions. The company reported a profit of $73.7 million, or 21 cents per share, after it lost $22.6 million, or 7 cents per share, a year ago.
Tags: purchase
outlook
completing
raises
Valeant victorious in battle for Salix, gets majority of drug maker's stock
2015-04-01 15:20:42| Biotech - Topix.net
Valeant Pharmaceuticals International Inc. says its US$11.1-billion friendly takeover bid for Salix Pharmaceuticals, Ltd. was successful, with about three-quarters of all Salix shares tendered by the deadline early Wednesday. Valeant's offer of US$173 in cash per Salix share defeated a rival bid from Dublin-based Endo International, which had offered a combination of stock and cash valued at about US$175 per share.
Tags: stock
drug
majority
battle
Valeant boosts offer for Salix Pharma to about $11.11B
2015-03-16 14:06:50| Biotech - Topix.net
Valeant is raising its offer for Salix Pharmaceuticals to about $11.11 billion, heating up a bidding fight for the company. The Canadian drug maker's new bid is for $173 per Salix share, a 2 percent premium over Friday closing price of $169.40.
Tags: offer
pharma
boosts
salix
Fight for Salix Gets Hot; Valeant Ups Bid to About $11.11B
2015-03-16 14:06:49| Biotech - Topix.net
Valeant turned up the heat in its bidding fight for Salix Pharmaceuticals on Monday, raising its offer to about $11.11 billion in cash. The Canadian drugmaker now says it will pay $173 per Salix share, a 2 percent premium over Friday's closing price of $169.40.